Gastrointestinal symptoms are common in children infected with SARS-CoV-2 and should trigger tests for the virus, according to investigators. This research comes after investigators earlier this month released results of a study of COVID-19 ocular manifestations in children in China.
Study designed to identify patterns in abnormalities and differences characteristic of disease.
Humoral immunity against SARS-CoV-2 may not last long in individuals who had mild infections, and the loss of antibodies may actually be quicker than reported previously for the virus, according to investigators from the David Geffen School of Medicine, University of California, Los Angeles.
Changes after DMEK, UT-DSAEK may be factors in reduced total corneal refractive power
Ocular comorbidities diminish BCVA results
Relational thickness altered tool details LASIK impact on the cornea.
RLE, in unexpected twist, is gaining support among surgeons
Nanodrop technology improves lens comfort
A new study out of Wuhan, China where the novel coronavirus was first detected in late 2019 found that some children hospitalized with COVID-19 presented with series of onset symptoms that included conjunctival discharge, eye rubbing, and conjunctival congestion.
Wearing a face mask can help slow the spread of COVID-19, and may also lead to a spike in cases of dry eye. The Centre for Ocular Research and Education at the University of Waterloo, Ontario, Canada, is advising eye care professionals on how to recognize and mitigate mask-associated dry eye.
Organization kicks off initiative as it views mental health as a key public health concern in the WHO European region, where more than 110 million people are living with some type of mental health issue.
A New York City physician describes how he coped with the disease in the early days of its US appearance as well as the silver lining in his diagnosis: a reinforcement of the doctor-patient relationship.
Investigators note the need for less medication over 12-month period
The FDA on Sunday issued an emergency use authorization to allow treatment with COVID-19 convalescent plasma for patients who are hospitalized with the disease.
Pandemic is disrupting clinical facilities, putting individuals’ ocular health at risk
Research results can help ophthalmologists treating patients with macular edema
Investigators examine and analyze outcomes of aflibercept compared with laser treatment in patients
The use of a human monoclonal antibody (Narsoplimab, Omeros) to treat acute respiratory distress syndrome (ARDS) associated with COVID-19 resulted in recovery and survival of the affected patients.
According to a recent study, communities across the country are dealing with an increased number of mental health challenges due to “COVID-19–associated morbidity, mortality, and mitigation activities.”
Emerging technology may be able to fill existing imaging diagnostic gaps
Following cataract surgery, the dropless option is proving to be a preferred method during recovery
Researchers note that more study of conjunctivitis is needed in patients with COVID-19
Gene therapy to treat choroideremia shows potential for maintaining or improving vision
Machine-learning algorithms have potential to predict patients with nonproliferative diabetic retinopathy who will or will not improve over time.
An ophthalmologist details how the COVID-19 crisis has helped him focus on essentials
Intravitreal injection offers safety, efficacy, and improved vision in patients
Reduced quality of life, mental health issues are major adverse effects of TED
For many physicians, "moral injury" may be an actual issue
An inhaled formulation of interferon beta, significantly decreased the chances of hospitalized patients developing severe COVID-19 compared to placebo.
How gonioscopy can offer ophthalmologists an option in treating patients with glaucoma
